Corrigendum to ``A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation''. [Journal of Affective Disorders 251 (2019) 205-212]
1 The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.
2 The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.
3 Clinical Affective Neuroimaging Laboratory, Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany.
4 Clinical Affective Neuroimaging Laboratory, Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany; Magnetic Resonance Spectroscopy in Psychiatry, Neuropsychiatric Imaging Group, Max Planck Institute for Biological Cybernetics, Tuebingen, Germany.
5 The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, China.
6 The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China. Electronic address: ningjeny@126.com.